LaVoie Group Adds Analytics Software Company to Client Roster

  LaVoie Group Adds Analytics Software Company to Client Roster

   i3 Analytics Develops Web-based Software for Pharma, Biotech Industries

Business Wire

CAMBRIDGE, Mass. -- November 16, 2012

LaVoie Strategic Communications, Inc. “LaVoie Group,” a firm with a proven
track record of building value for health science innovations through
integrated communications and investor relations, is pleased to announce that
it was selected in a competitive pitch to be the PR agency for i3 Analytics, a
Maryland company providing deep insight into unstructured data and
pharmaceutical industry trends.

“i3 Analytics is a young, innovative company that provides a web-based
software to pharmaceutical companies and related industries, enabling them to
make business development, R & D and other decisions based on accurate and
efficient analysis of data from scientific research, clinical trials and
regulatory submissions,” said Donna LaVoie, president and CEO of LaVoie Group.
“We are thrilled to be partnering with the i3 team.”

The leadership team at i3 Analytics selected LaVoie Group because the firm has
significant experience in the life sciences and health care sectors, enhancing
i3’s access to the industry.

“LaVoie Group has a strong reputation and wide reach within life sciences,
biotechnology, pharmaceuticals, device and health care,” said Will Zerhouni,
president and CEO of i3. “LaVoie Group’s strategic counsel, proprietary
database and execution add value to our business development efforts.”

Since forming in 2011, i3 has worked exclusively on behalf of one of the
world’s top-five pharmaceutical companies. Now the Biopharma Navigator,
developed in partnership with that company, is available for small to mid-size
biotech and pharmaceutical companies and other life science companies.

About i3 Analytics

i3 Analytics is empowering biopharmaceutical companies and related industries
to make fast, informed and intelligent decisions on business strategy,
clinical affairs and product development. i3 Analytics’ flagship product is
the Biopharma Navigator, analytics software that provides an intuitive map of
the biopharma landscape. The Biopharma Navigator is a single entry point that
provides access to focused search lenses, including the ClinicalTrials
Navigator, BioExpert Navigator, and BioNews Navigator. The company’s
intuitive, accessible analytics tools navigate the complex world of data from
scientific research, clinical trials and regulatory submissions in the US and
Europe. For more information, visit:

About LaVoie Group

LaVoie Group partners with its clients achieve their business goals by
providing strategic consulting and integrated communications programs that
properly position, engage target customers and stakeholders to create brand
value. LaVoie Group is part of the IPREX network of global agencies.

LaVoie Group clients are industry leaders in healthcare and government
markets, including, Aegerion Pharmaceuticals, AliveCor, Vertex
Pharmaceuticals, BIO, Radius Health, Novadaq Technologies, Rockwell Medical,
the Commonwealth of Massachusetts, Flagship Ventures, MPM Capital, Hydra
Biosciences and Xcovery Group of companies. LaVoie Group is part of INC.
500/500 private company list and is ranked by O’Dwyer’s PR Report as one of
the leading independent healthcare PR firms in the U.S. and has been honored
for the past four years by the League of American Communications Professionals
(LACP) for best agency awards, including the 2011 “Best Small Agency”. The
agency has been honored by eighteen awards in the last three years.


LaVoie Group
David Connolly, 617-374-8800
Vice President
Press spacebar to pause and continue. Press esc to stop.